Washington, D.C. — April 21. Americans for Medical Progress (AMP) issued a statement responding to the FDA’s “Year 1” roadmap update on reducing animal testing in drug development. The statement highlights concerns about inconsistencies between the agency’s public messaging and its own scientific guidance and review practices.

AMP emphasizes that, “For FDA’s roadmap to succeed, its implementation must be as honest as its aspirations are ambitious.” Ensuring alignment between public messaging and scientific reality is essential to maintaining trust, protecting patient safety, and clearly communicating the continued importance of animal research in drug development.

View AMP’s statement here.